These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2215535)

  • 1. Use of a composite polyfunctional model electrophile as a probe to analyze the performance of an artificial intelligence structure-activity method.
    Rosenkranz HS; Klopman G
    Mutat Res; 1990 Oct; 232(2):249-60. PubMed ID: 2215535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural alerts to genotoxicity: the interaction of human and artificial intelligence.
    Rosenkranz HS; Klopman G
    Mutagenesis; 1990 Jul; 5(4):333-61. PubMed ID: 2398817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A computerized connectivity approach for analyzing the structural basis of mutagenicity in Salmonella and its relationship with rodent carcinogenicity.
    Perrotta A; Malacarne D; Taningher M; Pesenti R; Paolucci M; Parodi S
    Environ Mol Mutagen; 1996; 28(1):31-50. PubMed ID: 8698045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical carcinogenicity: can it be predicted from knowledge of mutagenicity and allergic contact dermatitis?
    Rosenkranz HS; Karol MH
    Mutat Res; 1999 Dec; 431(1):81-91. PubMed ID: 10656488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology Program.
    Ashby J; Tennant RW; Zeiger E; Stasiewicz S
    Mutat Res; 1989 Jun; 223(2):73-103. PubMed ID: 2662004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural relationships between mutagenicity, maximum tolerated dose, and carcinogenicity in rodents.
    Rosenkranz HS; Klopman G
    Environ Mol Mutagen; 1993; 21(2):193-206. PubMed ID: 8444146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 39 chemicals tested for carcinogenicity by the U.S. National Toxicology Program.
    Tennant RW; Ashby J
    Mutat Res; 1991 May; 257(3):209-27. PubMed ID: 2014033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Commission for Protection Against Environmental Mutagens and Carcinogens. Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE.
    Klopman G; Rosenkranz HS
    Mutat Res; 1994 Feb; 305(1):33-46. PubMed ID: 7508546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP.
    Ashby J; Tennant RW
    Mutat Res; 1988 Jan; 204(1):17-115. PubMed ID: 3277047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP.
    Ashby J; Tennant RW
    Mutat Res; 1991 May; 257(3):229-306. PubMed ID: 1707500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Commission for Protection Against Environmental Mutagens and Carcinogens. Application of SAR methods to non-congeneric data bases associated with carcinogenicity and mutagenicity: issues and approaches.
    Richard AM
    Mutat Res; 1994 Feb; 305(1):73-97. PubMed ID: 7508549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagens that are not carcinogens: faulty theory or faulty tests?
    Zeiger E
    Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of newly recognized relationships between mutagenicity, genotoxicity and carcinogenicity of molecules.
    Rosenkranz HS; Zhang YP; Klopman G
    Mutat Res; 1991; 250(1-2):25-33. PubMed ID: 1944342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-aided analysis of mutagenicity and cell transformation data for assessing their relationship with carcinogenicity.
    Taningher M; Malacarne D; Perrotta A; Parodi S
    Environ Mol Mutagen; 1999; 33(3):226-39. PubMed ID: 10334625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
    Ashby J; Paton D
    Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New structural concepts for predicting carcinogenicity in rodents: an artificial intelligence approach.
    Rosenkranz HS; Klopman G
    Teratog Carcinog Mutagen; 1990; 10(2):73-88. PubMed ID: 1973857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Cryptic' mutagens and carcinogenicity.
    Rosenkranz HS; Klopman G
    Mutagenesis; 1990 Mar; 5(2):199-202. PubMed ID: 2188075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk identification using structural concepts: the potential carcinogenicity of praziquantel.
    Rosenkranz HS; Zhang YP; Klopman G
    Regul Toxicol Pharmacol; 1995 Oct; 22(2):152-61. PubMed ID: 8577950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenicity of the aromatic amines: from structure-activity relationships to mechanisms of action and risk assessment.
    Benigni R; Passerini L
    Mutat Res; 2002 Jul; 511(3):191-206. PubMed ID: 12088717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.